PRESS RELEASE published on 08/04/2026 at 15:56, 1 month 7 days ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc The Vanguard Group, Inc. discloses a 5.65% interest in SEGRO plc. Details include 76,487,985 securities owned and a purchase of 21,729 at 9.61 GBP per unit Securities The Vanguard Group Stock Purchase Financial Disclosure SEGRO PLC
PRESS RELEASE published on 08/04/2026 at 15:54, 1 month 7 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses 2.71% stake in Schroders plc through Form 8.3 according to Takeover Code. Details on securities holdings revealed Form 8.3 Takeover Code Schroders Plc Vanguard Group Securities Holdings
PRESS RELEASE published on 08/04/2026 at 15:53, 1 month 7 days ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc. The Vanguard Group, Inc. discloses a position in Prologis, Inc. securities as of 03 Aug 2026. Additional disclosures made for SEGRO plc. Details in Form 8.3 filing Securities Disclosure Vanguard Group SEGRO PLC Prologis Inc.
PRESS RELEASE published on 08/04/2026 at 15:52, 1 month 7 days ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited The Vanguard Group, Inc. discloses 4.29% stake in Picton Property Income Limited according to Form 8.3. Details of positions, dealings & other information revealed Form 8.3 Financial Dealings Securities Disclosure Vanguard Group Picton Property Income Limited
BRIEF published on 08/04/2026 at 15:44, 1 month 7 days ago Vanguard Group Discloses Stake in Beazley plc Rule 8.3 Vanguard Group Stake Disclosure Securities Interest Beazley Plc
PRESS RELEASE published on 08/04/2026 at 15:39, 1 month 7 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 4.99% interest in Beazley plc's 5p ordinary shares. Details of the disclosure as per Form 8.3 Securities Form 8.3 Disclosure Vanguard Group Beazley Plc
BRIEF published on 08/03/2026 at 15:25, 1 month 8 days ago The Vanguard Group's Form 8.3 Filing on Tate & Lyle plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Tate & Lyle
BRIEF published on 08/03/2026 at 15:24, 1 month 8 days ago Vanguard Group Discloses Position in Spire Healthcare Form 8.3 Takeover Code Vanguard Group Spire Healthcare Securities Position
BRIEF published on 08/03/2026 at 15:22, 1 month 8 days ago The Vanguard Group Discloses 5.65% Stake in SEGRO plc Form 8.3 Securities Disclosure Vanguard Group Shareholding SEGRO PLC
BRIEF published on 08/03/2026 at 15:21, 1 month 8 days ago The Vanguard Group Discloses Position in Schroders plc Takeover Code Schroders Plc Vanguard Group Share Transactions Stock Disclosure
Published on 09/12/2026 at 02:35, 1 hour 8 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 4 hours 43 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 5 hours 38 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 6 hours 18 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 10 hours 43 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 22:15, 5 hours 28 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 5 hours 33 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 7 hours 58 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 9 hours 28 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 20 hours 43 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 20 hours 43 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 1 day 8 hours ago Availability of the 2026 Interim Financial Report
